Since 2014, senior research fellow and lecturer at the Institute of Applied Simulations of the Zurich University of Applied Sciences (ZHAW). Editor of BMC Evol Biol and PLoS ONE. In 2012 edited a book in 2 volumes "Evolutionary Genomics: Statistical and computational methods".
Assistant Professor of Computation Genetics at Albert Einstein College of Medicine, NY.
I am an assistant professor of Microbiology and Immunology at Faculty of Pharmacy, Cairo University, Egypt. I am interested in microbial pathogenesis, microbial and phage genomics, microbiome research, pharmacomicrobiomics, antibiotic resistance surveillance, and virulence gene discovery.
Assistant Professor interested in evolutionary microbiology and genomics
I'm a Systems Biologist with a background in Biology, Genetics and Bioinformatics. I hold a PhD from the Aix-Marseille University. After a Post-Doc in the CNIO (Madrid, Spain), I got a CNRS Researcher position in 2010. I'm working since then in the Marseille Institute of Mathematics (CNRS-AMU). I'm interested in -omics studies (interactomes), Networks (partitioning, boolean modelling), and questions related to human diseases, in particular complex diseases, cancers and comorbidities.
1981-1985. Graduate Student, MRC Laboratory of Molecular Biology, Cambridge, U.K.
1985-1989. Postdoctoral Fellow Department of Biochemistry, University of California, Berkeley, CA.
1989-2000. Assistant and Associate Professor, Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT.
2000- Staff Scientist, Genomics Division, Lawrence Berkeley National Laboratory, Berkeley CA.
Deputy Head of Genomics Department at Naval Medical Research Center, Biological Defense Research Directorate; Adjunct Assistant Professor of Emerging Infectious Diseases at Uniformed Services University of the Health Sciences; Henry M. Jackson Foundation contractor
My primary research field is mammalian epigenetic control. My interests lie in using screens to identify novel epigenetic modifiers or new roles for known epigenetic modifiers, in order that we can expand our understanding of the molecular basis of epigenetic control. We study X chromosome inactivation in differentiating ES cells and early embryos, haematopoietic stem cells, neural stem cells and additionally study the role of the epigenetic modifier Smchd1 in the muscular dystrophy FSHD.
2013- Senior Lecturer, University of Manchester, Manchester, UK
2006-13 Lecturer, University of Manchester, Manchester, UK
2001-06 Junior Group Leader Max-Planck Institute of Immunobiology in Freiburg, Germany
2000-01 Postdoctoral Fellow, Max-Planck Institute of Immunobiology in Freiburg, Germany
1996 PhD, University of Genova, Italy and Institute of Molecular Pathology, Vienna, Austria
1989 Degree in Biological Sciences, University of Genoa, Italy
Associate Scientist, Childrens' Hospital Oakland Research Institute. Visiting Scholar, University of California, Berkeley.
At CHORI, we use genomic strategies to investigate the role of genetic and epigenetic variation in the regulatory domain of the genome, with an interest in both human disease and evolution. The two main areas of interest of the lab are:The evolutionary biology and potential contribution to human disease of components of the epigenome. And, annotating the regulatory elements of the human genome using a combination of comparative analysis of sequenced vertebrate genomes and public epigenomic datasets.
Laura Boykin is a Research Fellow at The University of Western Australia. She is interested in using genomic data to answer real-world problems. Specifically she is interested in invasive species, particularly Bemisia tabaci (whiteflies). Other areas of interest are: comparative genomics, phylogenetic analyses (of DNA sequences) and also high performance computing. Combining all of the above to help smallholder famers in Africa is her ultimate goal. She was recently named a TED 2015 and presented her work on cassava whitefly at TED in Vancouver.